This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scenitfique, Université Grenoble Alpes. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 182 
Years Active: 2026
Title: Salia Tangara: Research on Enzyme-Stabilizing Compounds
Introduction
Salia Tangara is an inventor associated with Lille, France. His work includes a patent on compounds designed to stabilize human acid α-glucosidase, an enzyme relevant to Pompe disease research.
Latest Patents
Tangara is listed as an inventor on 1 patent: “Pharmacological Chaperone Compounds of Human Acid α-Glucosidase and the Therapeutic Use Thereof.” The invention describes piperidine-ring iminosugars with a D-gluco configuration and a quaternary center adjacent to the ring’s nitrogen. These compounds are designed to stabilize human acid α-glucosidase selectively compared with other glycosidases. The patent identifies their potential use as pharmacological chaperones in the treatment of Pompe disease.
Career Highlights
Tangara’s listed affiliations include Université Grenoble Alpes and the French National Centre for Scientific Research (CNRS). His patent reflects research into selective enzyme stabilization and potential therapeutic applications.
Collaborations
The listed collaborators include Sandrine Py and Anaïs Vieira Da Cruz.
Conclusion
Salia Tangara’s patent documents research into selective α-glucosidase-stabilizing compounds and their potential application as chaperone molecules for Pompe disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile